[1] Kratzer W,Mason R A,Kachele V.Prevalence of gallstones in sonographic surveys worldwide. J Clin Ultrasound,2015,27(1):1-7. [2] Chen JY,Hsu CT,Liu JH,et al.Clinical predictors of incident gallstone disease in a Chinese population in Taipei,Taiwan. Bmc Gastroenterol,2014,14(1):83. [3] Mishra T,Lakshmi KK,Peddi KK.Prevalence of cholelithiasis and choledocholithiasis in morbidly obese South Indian patients and the further development of biliary calculus disease after sleeve gastrectomy,gastric bypass and mini gastric bypass. Obes Surg,2016,26(10):1-7. [4] Pak M,Lindseth G.Risk factors for cholelithiasis. Gastroenterol Nursing,2016,39(4):297. [5] Tuna Kirsaclioglu C, Bahar, Bayram G,et al.Risk factors,complications and outcome of cholelithiasis in children:A retrospective,single-centre review. J Paediatr Child Health,2016,52(10):944-949. [6] Alberti KG,Eckel RH,Grundy SM,et al.Harmonizing the metabolic syndrome:a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention;National Heart,Lung,and Blood Institute;American Heart Association;World Heart Federation;International A. Circulation,2009,120(16):1640-1645. [7] 赵登科,赵彩霞. 疏肝利胆通泄法联合熊去氧胆酸治疗胆结石合并慢性胆囊炎患者疗效初步研究. 实用肝脏病杂志,2017,20(5):633-634. [8] 刘通,高海静,王万超,等. 代谢综合征对新发胆石症的预测价值. 中华消化外科杂志,2017,16(6):608-613. [9] Sang JH,Ki NK,Cho JH,et al.Correlations between metabolic syndrome,serologic factors,and gallstones. J Phys Ther Sci,2016,28(8):2337-2341. [10] Jamal MH,Singh M.47 gallbladder and biliary disease in bariatric surgery patients//Minimally invasive bariatric surgery. Springer New York,2015:441-446. [11] Chen Y,Kong J,Wu S.Cholesterol gallstone disease: focusing on the role of gallbladder. Lab Invest,2015,95(2):124-131. [12] Tosheska TK,Topuzovska S.High-density lipoprotein metabolism and reverse cholesterol transport:strategies for raising HDL cholesterol:Anatol [J] Cardiol,2017,18(2):149-154. [13] Kim SB,Kim KH,Kim TN,et al.Sex differences in prevalence and risk factors of asymptomatic cholelithiasis in Korean health screening examinee:A retrospective analysis of a multicenter study. Medicine (Baltimore),2017,96(13):e6477. [14] Atamer A,Kurdas-Ovunc AO,Yesil A,et al.Evaluation of paraoxonase,malondialdehyde,and lipoprotein levels in patients with asymptomatic cholelithiasis. Saudi J Gastroenterol,2014,20(1):66-73. [15] Welzel TM,Graubard BI,Zeuzem S,et al.Metabolic syndrome increases the risk of primary liver cancer in the United States:a population-based case-control study. Hepatology,2011,54(2):463-471. [16] Ahmed F,Baloch Q,Memon ZA,et al.An observational study on the association of nonalcoholic fatty liver disease and metabolic syndrome with gall stone disease requiring cholecystectomy. Ann Med Surg (Lond),2017,17:7-13. [17] Lin IC,Yang YW,Wu MF,et al.The association of metabolic syndrome and its factors with gallstone disease. BMC Fam Pract,2014,15:138. [18] Shen C,Wu XL,Xu CF,et al.Association of cholecystectomy with metabolic syndrome in a Chinese population. PLoS One,2014,9(2):e88189. [19] Shebl FM,Andreotti G,Meyer TE,et al.Metabolic syndrome and insulin resistance in relation to biliary tract cancer and stone risks:a population-based study in Shanghai, China. Br J Cancer,2011,105(9):1424-1429. [20] Chen LY,Qiao QH,Zhang SC,et al.Metabolic syndrome and gallstone disease. World J Gastroenterol,2012,18(31):4215-4220. |